Evidence map›Paper›PMID 39201577›Full record

ArticleInternational journal of molecular sciences2024

A One-Month Advanced Glycation End Products-Restricted Diet Improves CML, RAGE, Metabolic and Inflammatory Profile in Patients with End-Stage Renal Disease Undergoing Haemodialysis.

Adamantia Aroni, Paraskevi Detopoulou, Demetrios Presvelos, Eirini Kostopoulou, Anastasios Ioannidis, George I Panoutsopoulos, Sofia Zyga, Georgios Kosmidis, Bessie E Spiliotis, Andrea Paola Rojas Gil

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adamantia AroniLaboratory of Basic Health Sciences, Department of Nursing, Faculty of Health Sciences, University of Peloponnese, 22100 Tripoli, Greece.
Paraskevi DetopoulouDepartment of Nutritional Science and Dietetics, Faculty of Health Sciences, University of Peloponnese, New Building, Antikalamos, 24100 Kalamata, Greece.ORCID 0000-0003-1723-9192
Demetrios PresvelosHaemodialysis Unit, General Hospital of Molaoi, 23052 Molaoi, Greece.
Eirini KostopoulouDepartment of Paediatrics, Research Laboratory of the Division of Pediatric Endocrinology and Diabetes, University of Patras School of Medicine, 26504 Patras, Greece.ORCID 0000-0002-7051-7537
Anastasios IoannidisLaboratory of Basic Health Sciences, Department of Nursing, Faculty of Health Sciences, University of Peloponnese, 22100 Tripoli, Greece.ORCID 0000-0003-1880-7366
George I PanoutsopoulosDepartment of Nutritional Science and Dietetics, Faculty of Health Sciences, University of Peloponnese, New Building, Antikalamos, 24100 Kalamata, Greece.
Sofia ZygaLaboratory of Nursing Research and Care, School of Health Sciences Department of Nursing, University of Peloponnese, 22100 Tripoli, Greece.
Georgios KosmidisLaboratory of Basic Health Sciences, Department of Nursing, Faculty of Health Sciences, University of Peloponnese, 22100 Tripoli, Greece.
Bessie E SpiliotisDepartment of Paediatrics, Research Laboratory of the Division of Pediatric Endocrinology and Diabetes, University of Patras School of Medicine, 26504 Patras, Greece.ORCID 0000-0001-7922-4012
Andrea Paola Rojas GilLaboratory of Basic Health Sciences, Department of Nursing, Faculty of Health Sciences, University of Peloponnese, 22100 Tripoli, Greece.ORCID 0000-0002-9812-2131

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exogenous and endogenous advanced glycation end products (AGEs) contribute to the pathogenesis and progression of renal disease. This is a one-month controlled dietary counseling trial that restricts nutritional AGEs in patients with end-stage renal disease (ESRD) undergoing haemodialysis (

Indexed as

Glycation End Products, AdvancedKidney Failure, ChronicLysineReceptor for Advanced Glycation End ProductsRenal DialysisAdultAgedBiomarkersCyclooxygenase 2FemaleHumansInflammationMaleMiddle AgedBiomarkersCyclooxygenase 2Glycation End Products, AdvancedLysineN(6)-carboxymethyllysineReceptor for Advanced Glycation End ProductsAGEschronic kidney diseasediethaemodialysis

Identifiers

PMID39201577
PMCPMC11354996

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.